(b)(4).Our manufacturing process was within control and no abnormality was found on the given product lot.The product lot met all the qa outgoing inspection criteria prior releasing to the market.Based on the results of reserved samples evaluation and dhr analysis, there was no abnormality found on complaint lot.Investigation was carried out based on the reported lot 180608332.Based on the results of dhr analysis and reserve samples evaluation, there was no abnormality found on the reported product lot.We would like to emphasize that our manufacturing process was within control and all our products met the jms qa outgoing inspection criteria prior to market release.As per the information provided by facility and jmsna, no defect or malfunction was observed of the jms sysloc mini avf.Hence, this incident is not related to our manufacturing process.Nonetheless, briefing was conducted on 26 dec 2018 to all related operators and inspectors for their awareness on the reported defect.(b)(4).
|
On (b)(6) 2018, a hemodialysis patient, approximately 45 minutes into a scheduled 3.5 hour hemodialysis treatment, the venous fistula needle was found to be leaking blood around the cannulation site.Staff reported venous needle was partially dislodged.The tape was intact on the wings of the fistula needle and secured to the patient.The patient was unresponsive to verbal commands.Vs: b/p: 79/39, pulse: 104.Blood was partially returned via the venous fistula needle.The venous cannulation site infiltrated and the remaining blood was returned via the arterial fistula needle.Approximately 800 mls normal saline was administered.Ems was called.Upon discharge from the facility via ems, b/p was 101/69, pulse 100, resp 18.The patient was awake and alert upon discharge.He was admitted to the hospital.2 units of packed red blood cells (prbcs) were infused.The patient returned to the facility for hemodialysis on (b)(6) 2018.
|